使用基于患者入院实验室参数的机器学习算法来预测COVID-19患者的不良结果
Yuchen Fu1,2, Xuejing Xu1, Juan Du3
1Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Heliyon
|May 3, 2024
概括
这项研究引入了一种机器学习模型,使用常规临床实验室测试来快速预测患者的生存率. 该模型实现了高精度,为临床医生提供了一个快速而精确的预后工具.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的机器学习
- 临床预后 临床预后
背景情况:
- 随着COVID-19的流行,人们越来越需要快速的患者预后.
- 准确的生存评估对于及时的临床决策至关重要.
- 现有的预测工具可能缺乏速度或依赖于复杂的数据.
研究的目的:
- 开发一种机器学习模型,利用现有的临床实验室数据来预测患者的生存率.
- 为临床医生创建一个快速而准确的预后评估工具.
- 确定能够预测患者结果的关键实验室参数.
主要方法:
- 用例行临床实验室测试数据用于模型开发.
- 集成的特征选择和二进制分类算法.
- 采用了联合拉索和支向量机 (SVM) 方法.
- 通过参数控制优化算法选择.
主要成果:
- 使用8个临床实验室参数开发了一个预测模型.
- 实现了0.9277.7的ROC曲线下的面积 (AUC).
- 证明了使用基本实验室数据进行预后的有效性.
结论:
- 机器学习模型可以使用简单的实验室测试有效地预测患者的生存率.
- 开发的模型为临床医生提供了一个快速而精确的预后工具.
- 这种方法简化了数据处理,并增强了临床决策支持.
相关概念视频
Steps in Outbreak Investigation
124
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
124
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133


